Buy This Small Cap Stock For Short Term, You Will Make Good Profit; Know The Brokerage Targets
Stocks to Buy: Due to positive global signals, the domestic stock market is witnessing a great boom on Wednesday (7 August).
The market opened strong. Amid this boom, a lot of stocks appear attractive on the chart for technical reasons.
A top brokerage firm has chosen Dr. Lal PathLabs (NSE: LALPATHLAB) as a technical pick from the pharma sector.
The brokerage has given Dr. Lal PathLabs an upside target of up to 6 percent for 2-3 days.
Indian market prices are off to a good start today. Nifty was up 300 points, while Sensex was also trading around 1,000 points higher.
Nifty Bank had gained more than 500 points. The IT index was up 2%. IT stocks were registering the highest growth.
Apart from this, NBFCs and government shares were also trading with a good jump.
Dr. Lal PathLabs: Good Earnings In 2-3 Days
The brokerage firm has made Dr. Lal PathLabs an option for technical analysis. It has also set a price target of 3350 rupees for this pharma stock over the next two to three days.
The stock traded at 3168 rupees on the 6th of August, 2024. This way the stock could rise 5-6 percent over its current price.
Dr. Lal PathLabs: Stock Jumped 37% In 3 Months
In the bullish market, Dr. Lal PathLabs started trading on the green mark on Wednesday. This stock experienced significant growth over the past year.
In the past year, the stock has earned a return of around 33 percent. Since 2024 the stock has gained by 24 %.
At the same time, it has yielded 26 percent in the last 6 months, and 37 percent over three months.
It has increased around 10 percent in just one month. The stock’s 52-week high on BSE is 3,208.25 and the low is 1,943.20. The company’s market cap is more than Rs 26,456 crore.
Disclaimer: This site is only for informational purposes. We do not provide any stoke recommendations or buying advice. We are here to give you the latest news and updates about the share market. We are not responsible for any loss.
